pain
| 4 min read
The drug, ubrogepant, mitigated many of the symptoms that precede the worst of a migraine and hinted at the condition’s origin.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 3 min read
Back pain affects millions of people worldwide, but a new combination treatment that targets senescent cells in the spine may one day provide relief.
| 5 min read
What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.
| 3 min read
A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.
| 3 min read
Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
| 3 min read
Researchers developed a new pill with promising applications for treating pain due to gastrointestinal disorders.
| 9 min read
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
Available on Demand
Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief.
Page 1 of 3 - 22 Total Items
